Curcumin and Related Compounds in Cancer Cells: New Avenues for Old MoleculesMatteo Costantino(Fondazione IRCCS Istituto Nazionale dei Tumori), Paola Perego(Fondazione IRCCS Istituto Nazionale dei Tumori)Frontiers in PharmacologyMay 24, 202210.3389/fphar.2022.889816Cited by 33SaveCiteExport RISWatch citationsRelated PapersHistone deacetylase inhibitor-temozolomide co-treatment inhibits melanoma growth through suppression of Chemokine (C-C motif) ligand 2-driven signals|Oncotarget|2014|30